PlainRecalls
FDA Drug Moderate Class II Terminated

Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61

Reported: July 8, 2020 Initiated: June 12, 2020 #D-1360-2020

Product Description

Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61

Reason for Recall

CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.

Details

Recalling Firm
The Harvard Drug Group
Units Affected
1,906 Cartons
Distribution
Nationwide USA
Location
Livonia, MI

Frequently Asked Questions

What product was recalled?
Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61. Recalled by The Harvard Drug Group. Units affected: 1,906 Cartons.
Why was this product recalled?
CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 8, 2020. Severity: Moderate. Recall number: D-1360-2020.